ImmuCell Corporation Payment for Contingent Consideration Liability, Investing Activities
ImmuCell Corporation (ICCC) reported Payment for Contingent Consideration Liability, Investing Activities of $8.91 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities · last filed 2021-03-30
- ImmuCell Corporation payment for contingent consideration liability, investing activities for the quarter ending 2019-12-31 was $0.00.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for the quarter ending 2019-06-30 was $0.00.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for the quarter ending 2019-03-31 was $8.91K, a 55.76% increase year-over-year.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for fiscal 2019 was $8.91K, a 36.68% decline from fiscal 2018.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for fiscal 2018 was $14.08K, a 62.53% increase from fiscal 2017.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for fiscal 2017 was $8.66K, a 95.46% increase from fiscal 2016.
- ImmuCell Corporation payment for contingent consideration liability, investing activities for fiscal 2016 was $4.43K.
| Period end | Payment for Contingent Consideration Liability, Investing Activities 3 month | Payment for Contingent Consideration Liability, Investing Activities 6 month | Payment for Contingent Consideration Liability, Investing Activities 9 month | Payment for Contingent Consideration Liability, Investing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $8.91K 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $8.91K 10-Q · filed 2020-11-12 | $8.91K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $8.91K 10-Q · filed 2020-08-12 | $8.91K derived: sum of 3 quarters · filed 2020-08-12 | $17.27K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $8.91K 10-Q · filed 2020-05-13 | $8.91K derived: sum of 2 quarters · filed 2020-05-13 | $17.27K derived: sum of 3 quarters · filed 2020-05-13 | $17.27K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $8.35K derived: sum of 2 quarters · filed 2020-03-27 | $8.35K derived: sum of 3 quarters · filed 2020-03-27 | $14.08K 10-K · filed 2020-03-27 |
| 2018-09-30 | $8.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $8.35K derived: sum of 2 quarters · filed 2019-11-12 | $14.08K 10-Q · filed 2019-11-12 | $14.08K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $5.72K 10-Q · filed 2019-08-12 | $5.72K derived: sum of 3 quarters · filed 2019-08-12 | $10.62K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $5.72K 10-Q · filed 2019-05-13 | $5.72K derived: sum of 2 quarters · filed 2019-05-13 | $10.62K derived: sum of 3 quarters · filed 2019-05-13 | $10.62K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $4.89K derived: sum of 2 quarters · filed 2019-03-22 | $4.89K derived: sum of 3 quarters · filed 2019-03-22 | $8.66K 10-K · filed 2019-03-22 |
| 2017-09-30 | $4.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $4.89K derived: sum of 2 quarters · filed 2018-11-13 | $8.66K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $3.77K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $3.77K 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | $4.43K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |